Cell quality inspection

Qualification Certification The first testing institution in the field of cell therapy in Southwest China to obtain CMA (2019) and CNAS (2022) certification. CNAS accreditation covers 10 testing objects and 230 parameters, and its reports have been mutually recognized by over 100 countries/regions worldwide.

10+ Covering 10 detection objects
230+
230 parameters
100+
Mutual recognition among over 100 countries/regions worldwide

hardware facilities We have a 1200m ² GMP standard quality control laboratory equipped with over 200 sets of key instruments and equipment, such as flow cytometry, fluorescence PCR, etc.

1200+
1200m ² GMP standard quality control laboratory
200+
Equipped with over 200 sets of key instruments and equipment

detection capability Over 100 testing methods have been established and validated, and more than 140 standard operating procedures have been developed, which can meet the requirements for clinical trial applications of cell drugs, testing of clinical phase I-III trial samples, and commercial production of cell drugs.

100+
100+testing methods
140+
More than 140 standards

Forward looking capacity layout To match the clinical promotion of pipeline and future strategic layout, a new generation comprehensive quality inspection base is being built based on the Cell Therapy Incubation Acceleration Park. The total planned construction area exceeds 5000m ², with production capacity matching the production needs of 800 batches/year for SDT-M/SDT-T products and 300 batches/year for UCAR-T products.

5000+
The total planned construction area exceeds 5000m ²
800+
800 batches of M/SDT-T products per year
300+
UCAR-T products 300 batches/year

What do you want to inquire about?